Clinical Trial Update: Vascular Inflammation in Psoriasis Trial (The VIP Trial) [Phase 4]

View source ↗

Summary

The VIP Trial (Phase 4) evaluating vascular inflammation in psoriasis has completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Psoriasis

Snippet

Sponsor: University of Pennsylvania | Conditions: Psoriasis, Cardiovascular Disease | Phase 4 | Status: COMPLETED | Results posted: 2018-05-22